GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synthorx Inc (NAS:THOR) » Definitions » YoY EPS Growth

Synthorx (Synthorx) YoY EPS Growth : 53.20% (As of Sep. 2019)


View and export this data going back to 2018. Start your Free Trial

What is Synthorx YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Synthorx's YoY EPS Growth for the quarter that ended in Sep. 2019 was 53.20%.

Synthorx's Earnings per Share (Diluted) for the three months ended in Sep. 2019 was $-0.38.


Synthorx YoY EPS Growth Historical Data

The historical data trend for Synthorx's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthorx YoY EPS Growth Chart

Synthorx Annual Data
Trend Dec16 Dec17 Dec18
YoY EPS Growth
- -86.98 -2,582.96

Synthorx Quarterly Data
Dec16 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only -35.11 -1,062.06 -38.34 15.58 53.20

Synthorx YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Synthorx's YoY EPS Growth for the fiscal year that ended in Dec. 2018 is calculated as:

YoY EPS Growth (A: Dec. 2018 )
=(Earnings per Share (Diluted) (A: Dec. 2018 )-Earnings per Share (Diluted) (A: Dec. 2017 ))/ | Earnings per Share (Diluted) (A: Dec. 2017 ) |
=(-18.11--0.675)/ | -0.675 |
=-2,582.96 %

Synthorx's YoY EPS Growth for the quarter that ended in Sep. 2019 is calculated as:

YoY EPS Growth (Q: Sep. 2019 )
=(Earnings per Share (Diluted) (Q: Sep. 2019 )-Earnings per Share (Diluted) (Q: Sep. 2018 )) / | Earnings per Share (Diluted) (Q: Sep. 2018 )) |
=(-0.38--0.812)/ | -0.812 |
=53.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthorx YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Synthorx's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthorx (Synthorx) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11099 North Torrey Pines Road, Suite 290, La Jolla, CA, USA, 92037
Executives
Powell Andrew Kenneth William director C/O COLLAGENEX PHARMACEUTICALS, INC., 41 UNIVERSITY DRIVE, NEWTOWN PA 18940
Ra Capital Healthcare Fund Lp 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Ra Capital Management, L.p. 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter Kolchinsky director, 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Peter A. Thompson director, 10 percent owner C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Rajeev M. Shah 10 percent owner 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116
Jay Lichter director C/O ARATANA THERAPEUTICS, INC., 11400 TOMAHAWK CREEK PARKWAY, SUITE 340, LEAWOOD KS 66211
Laura Shawver director, officer: President and CEO 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY NC 27518
Avalon Ventures X, L.p. 10 percent owner 1134 KLINE STREET, LA JOLLA CA 92037
Orbimed Advisors Llc director, 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Vii Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022